Schedule 13D ownership disclosure
Vera Therapeutics Inc
Security class unavailable · CUSIP: 92337R101
Event date: 2023-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-100524
- Form type
- SC 13D
- Filer
- Carlyle Group Inc.
- CIK
- CIK 1527166
- Filed
- Apr 13, 2023
- Reporting period
- Mar 28, 2023
- Description
- Schedule 13D beneficial ownership